Dynamics of findings of non-specific resistance in the mouth cavity in children with lesions of the mucous membrane epithelium of the mouth cavity against acute lymphoblastic leukemia in the treatment process.
DOI:
https://doi.org/10.26641/2307-0404.2020.1.200422Keywords:
nonspecific resistance, lisocyme, α-defensins, acute lymphoblastic leukemia, mucous membrane epithelium of the mouth cavityAbstract
There was conducted study of dynamics of findings of non-specific resistance in the mouth cavity in children with lesions of the mucous membrane epithelium of the mouth cavity against acute lymphoblastic leukemia in the treatment process by authors-developed methods. It is known that in children with leukemia immunodeficiency states develop immunological disorders resulted from treatment with cytotoxic drugs. Moreover, not only general, but also the local immunity of the mouth cavity suffers, which is accompanied by development of infectious processes in the tissues that perform the barrier function, which include mucous membrane epithelium of the mouth cavity. A key role in the system of antimicrobial protection of the mouth cavity is performed by mucolytic enzyme lisocyme and α-defensins (HNP 1-3). 76 children with acute lymphoblastic leukemia aged from 2 to 18 years suffering from such dental diseases as generalized chronic catarrhal gingivitis, erosive-ulcerative and candidal stomatitis took part in the clinical study. All children under clinical study were divided into 2 groups - the main and comparison. Standard protocol treatment was used in the comparison group. Developed treatment-and-prophylactic complex was used in the main group. The children of the main group were prescribed developed treatment-and-prophylactic complex depending on the period of the disease: the first version of local treatment was used in the acute period and the relapse of the disease, the second - in the period of remission. The results of research have shown a stimulating effect of therapeutic and prophylactic measures on the natural antimicrobial system of mouth cavity protection, both in children of the main groups under study and in the comparison groups. Such a phenomenon should be considered as a positive process that contributes to the increase of resistance in periodontal tissues and mucous membrane epithelium of the mouth cavity.
References
Gazhva SI, Tolkachyova NI. State of local immunity of the oral mucosa in patients with acute leukemias. Nizhegorodsky med. zhurnal. 2003; Suppl. Dentistry:103-5.
Lunitsyna YuV. Factors of local immunity in inflammatory-destructive diseases of the oral mucosa. Dental Yug. 2011;87(3):34-35.
Storozhuk PG, Safarova IV, Yerychev VV. Defining activity of saliva lisocyme. Clin. Lab. diagnostics. 2000;6:13-15.
Guani-Guerra E, Santos-Mendosa T, Lugo-Reyes SO, Teran LM. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin. Immunol. 2010;135(1):1-11. doi: https://doi.org/10.1016/j.clim.2009.12.004
Hua J, Scott RW, Dimond G. Activity of antimicrobial peptide mimetics in the oral cavity: II. Activity against periopathogenic biofilms and anti-inflammatory activity. Mol. Oral. Microbial. 2010;25(6):426-32. doi: https://doi.org/10.1111/j.2041-1014.2010.00591.x
Khotimska Yu, Kovach I, Kravchenko L, Nazaryan R, Gargin V. Influence of ozone therapyon oral tissue in modeling of chronic recurrent aphthous stomatitis. Georgian medical newz. 2017;264(3):115-9.
Kim C, Slavinskay Z, Merril AR, Kaufmann SH. Human alpha-defensins neutralize toxins of the mono-ADP-ribosyltransferase family. Biochem J. 2006;399(2):225-9. doi: https://doi.org/10.1042/bj20060425
Kohlgraf KG, Pingel LC, Dietrich DE, Brogden KA. Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiol. 2010;5(1):99-113. doi: https://doi.org/10.2217/fmb.09.104
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
